ScreenCell® at the SU2C Scientific Summit 2026
We are delighted to announce ScreenCell®’s participation in the SU2C Scientific Summit 2026, held from January 29 to February 1 in Pasadena, California (USA). This major event will bring together researchers and industry professionals to discuss the latest breakthroughs in oncology. For ScreenCell®, it represents a prime opportunity to share our expertise, engage with world-renowned experts, and forge strategic collaborations.
Furthermore, ScreenCell® will deliver an oral presentation on January 31 during Session 4: “Minimally Invasive Measurements (Including Devices).” This will be a key moment to showcase our method for isolating Circulating Tumor Cells (CTCs). This approach is fully aligned with the evolution of prognostic practices toward less invasive, simpler, and more accessible solutions for patients.
"Transforming Cancer Monitoring: The Impact of Circulating Tumor Cells"
Our Chief Technical Officer, Sina Naserian, Ph.D., will represent ScreenCell® at this event and deliver an oral presentation titled: “Transforming Cancer Monitoring: The Impact of Circulating Tumor Cells.” This session is scheduled for January 31 from 2:45 PM to 3:00 PM (PST). Please note that the presentation will not be livestreamed, but will be followed by a Q&A session.
This gathering will be an ideal occasion for researchers, clinicians, and industry professionals to explore our non-invasive CTC isolation technology and discuss the practical applications of CTCs in clinical routine.
Would you like to learn more about our Circulating Tumor Cell isolation method?
Please express your interest by clicking the button below or by contacting us at: contact@screencell.com